natgillin/translations-raw huggingface dataset:
This does not mean that the owner is not classified as an undertaking within the meaning of the State aid rules, provided that he meets the determining criteria formulated by case law, namely that he is engaged in an activity consisting of supplying goods and services in a given market and that he does not merely have shareholdings and receive dividends.
To ne pomeni, da lastnik ni opredeljen kot podjetje v smislu pravil o državni pomoči, če izpolnjuje merila, ki jih oblikuje sodna praksa, namreč, da opravlja dejavnost, ki na danem trgu zagotavlja dobrine in storitve ter se ne omeji le na lastništvo delnic in prejemanje dividend.
All the practical aspects of setting up and running the joint-ownership companies are undertaken by these managers or people presented by the Bank.
Za vse praktične vidike ustanovitve in vodenja solastniških družb so odgovorni ti upravljavci ali osebe iz banke.
At the joint-ownership’s general meeting (where, in theory the investors could exercise their rights over the vessel and its operation), the joint-ownership companies are represented not by their members but by their managers.
Na skupščini delničarjev solastništva (kjer bi teoretično lahko vlagatelji uveljavljali svoje pravice do ladje in njenega obratovanja) pa solastniških družb ne zastopajo njeni člani, ampak upravljavci.
This archipelago is not the ‘beneficiary country’ (which is Saint-Pierre-et-Miquelon). However, since both groups of islands are on the Commission’s list of countries eligible for development aid, the aid cannot be objected to on this ground.
To otočje sicer ni „država prejemnica“ (kar pa je otočje Saint-Pierre in Miquelon), ker pa sta obe otočji na seznamu Komisije, ki našteva države, ki bi lahko bile upravičene do razvojne pomoči, Komisija glede tega ne bo nasprotovala.
of 10 September 2008
z dne 10. septembra 2008
terminating the examination procedure concerning the measures imposed by the Republic of Korea affecting the import, distribution and advertising of cosmetics, perfume and toiletries products
o zaključku postopka preverjanja v zvezi z ukrepi, ki jih je uvedla Republika Koreja za uvoz, distribucijo in oglaševanje kozmetičnih izdelkov, dišav in izdelkov za osebno nego
(notified under document number C(2008) 4837)
(notificirano pod dokumentarno številko C(2008) 4837)
Having regard to Council Regulation (EC) No 3286/94 of 22 December 1994 laying down Community procedures in the field of the common commercial policy in order to ensure the exercise of the Community’s rights under international trade rules, in particular those established under the auspices of the World Trade Organisation [1] and in particular Article 11(1) thereof,
ob upoštevanju Uredbe Sveta (ES) št. 3286/94 z dne 22. decembra 1994 o določitvi postopkov Skupnosti na področju skupne trgovinske politike za zagotovitev izvrševanja pravic Skupnosti po mednarodnih pravilih trgovanja, zlasti tistih, ki so dogovorjena v okviru Svetovne trgovinske organizacije [1], in zlasti člena 11(1) Uredbe,
On 2 April 1998, COLIPA (European Cosmetic, Toiletry and Perfumery Association) lodged a complaint under Article 4 of Regulation (EC) No 3286/94 (hereinafter the Regulation) on behalf of those of its members which export to the Republic of Korea or wish to do so.
COLIPA (Evropsko združenje proizvajalcev kozmetičnih izdelkov, izdelkov za osebno nego in dišav) je 2. aprila 1998 v skladu s členom 4 Uredbe (ES) št. 3286/94 (v nadaljnjem besedilu „Uredba“) vložil pritožbo v imenu svojih članov, ki izvažajo ali želijo izvažati v Republiko Korejo.
The complainant alleged that the Community sales of cosmetics products in the Republic of Korea were hindered by various obstacles to trade within the meaning of Article 2(1) of the Regulation.
Pritožnik je trdil, da je bila prodaja kozmetičnih izdelkov Skupnosti v Republiki Koreji ovirana zaradi različnih trgovinskih ovir v smislu člena 2(1) Uredbe.
The alleged obstacles to trade were the following:
Domnevne trgovinske ovire so bile naslednje:
conformity assessment procedure whereby testing of imported cosmetics had to be carried out by the Korean Administration, in Korea;
postopek za ugotavljanje skladnosti, pri čemer je preskušanje uvoženih kozmetičnih izdelkov morala opraviti korejska uprava v Koreji;
burdensome administrative tracking of products, including providing sensitive commercial information to the Korean industry association;
zapleteno upravno sledenje izdelkov, vključno z zagotavljanjem občutljivih trgovinskih informacij korejskemu industrijskemu združenju;
discriminatory authorisation procedure for advertisements;
diskriminacijski postopek odobritve oglaševanja;
other practices: labelling procedures, the non-recognition of the EU inventory of cosmetics ingredients, the prohibition of gift with purchase and some advertising difficulties.
druge prakse: postopki označevanja, nepriznavanje popisa kozmetičnih sestavin EU, prepoved daril pri nakupu in nekatere težave pri oglaševanju.
The complainant also claimed that these practices were causing adverse trade effects within the meaning of Article 2(4) of the Regulation.
Pritožnik je prav tako trdil, da imajo te prakse škodljive učinke na trgovino v smislu člena 2(4) Uredbe.
The Commission decided therefore, after consultation of the Advisory Committee established by the Regulation, that there was sufficient evidence to justify initiating an examination procedure for the purpose of considering the legal and factual issues involved.
Zato je Komisija po posvetovanju s svetovalnim odborom, ustanovljenim z Uredbo, sklenila, da obstajajo zadostni dokazi za utemeljitev začetka postopka preverjanja za preučitev pravnih in dejanskih vprašanj.
Consequently, an examination procedure was initiated on 19 May 1998 [2].
Zato se je 19. maja 1998 [2] začel postopek preverjanja.
In 1999, the investigation concluded on the conformity assessment procedure that it was both discriminatory and more burdensome than necessary and therefore was in violation of Articles 5.1.1 and 5.1.2 of the WTO Agreement on Technical Barriers to Trade (TBT Agreement), mainly because the Korean products, contrary to imported cosmetics, were not subject to an authorisation procedure prior to being put on the market.
Leta 1999 je bilo s preiskavo ugotovljeno, da je bil postopek za preverjanje skladnosti diskriminacijski in bolj zapleten, kot je potrebno, s čimer sta bila kršena člena 5.1.1 in 5.1.2 Sporazuma STO o tehničnih ovirah v trgovini (Sporazum o TBT), zlasti zato, ker se za korejske izdelke v nasprotju z uvoženimi kozmetičnimi izdelki ni uporabljal postopek odobritve pred dajanjem na trg.
The compulsory documentation for the administrative tracking of products was found to create an unnecessary duplication of administrative work for importers and therefore contrary to Article 5.1.2 of the TBT Agreement.
Ugotovljeno je bilo, da obvezna dokumentacija za upravno sledenje izdelkov uvoznikom po nepotrebnem podvaja upravno delo in je torej v nasprotju s členom 5.1.2 Sporazuma o TBT.
As regards the advertising regime for cosmetics, the Commission did not find evidence that the legislation or its enforcement were discriminatory.
V zvezi s sistemom oglaševanja za kozmetične izdelke Komisija ni našla dokazov, da bi bila zakonodaja ali njeno uveljavljanje diskriminacijska.
Finally, with respect to the other practices mentioned in the complaint, the Korean Regulation on labelling had already been modified and the EU inventory had been recognised.
V zvezi z drugimi praksami, navedenimi v zahtevku, so korejski predpisi o označevanju že bili spremenjeni, popis EU pa je bil priznan.
No complaint was possible on the Korean regime for gift with purchase since a complete prohibition could also be found in some Member States.
Na korejski sistem v zvezi z darili pri nakupu se ni bilo možno pritožiti, saj je ta praksa tudi v nekaterih državah članicah popolnoma prepovedana.
The investigation also concluded that some of the investigated measures had cumulatively caused or threaten to cause adverse effects within the meaning of Article 2(4) of the Regulation.
S preiskavo je prav tako bilo ugotovljeno, da so nekateri od preiskovanih ukrepov kumulativno povzročili škodljive učinke ali so predstavljali tveganje za povzročitev škodljivih učinkov v smislu člena 2(4) Uredbe.
Following the investigation, an agreement on the elimination of the testing of imported cosmetics was reached through an Exchange of Letters at the end of July 1999.
Po preiskavi je z izmenjavo pisem konec julija 1999 bil dosežen sporazum o odpravi preskušanja uvoženih kozmetičnih izdelkov.
In the meantime, Korea introduced a new legislation on cosmetics regulating the manufacturing, distribution and sale of cosmetics and creating a new category of cosmetic products (functional cosmetics) for which more burdensome procedures were established as compared to ‘ordinary cosmetics’.
Medtem je Koreja sprejela novo zakonodajo v zvezi s kozmetičnimi izdelki, ki ureja proizvodnjo, distribucijo in prodajo kozmetičnih izdelkov in uvaja novo kategorijo kozmetičnih izdelkov („uporabni kozmetični izdelki“), za katero so bili določeni bolj zapleteni postopki v primerjavi s postopki za „navadne kozmetične izdelke“.
The Commission adopted a decision suspending the TBR procedure [3] in order to monitor the functioning and administration of the new rules on cosmetics.
Komisija je sprejela sklep o začasni prekinitvi postopka v zvezi s trgovinskimi ovirami (TBR) [3], da bi lahko spremljala delovanje in upravljanje novih pravil v zvezi s kozmetičnimi izdelki.
The provisional conclusion of the evaluation of the new regime in 2000 was that it was too burdensome and potentially trade restrictive.
Na podlagi ocene novega sistema, izvedene leta 2000, je bila sprejeta začasna sklepna ugotovitev, da je ta sistem preveč zapleten in potencialno omejujoč za trgovino.
Following a series of discussions with Korean authorities, substantial progress was achieved through two consecutive revisions of the Screening Rules for Functional Cosmetics by the Korean Food and Drug Administration (KFDA).
Po vrsti razprav s korejskimi organi je bil z dvema zaporednima revizijama pravil za pregled uporabnih kozmetičnih izdelkov, ki ju je opravila korejska uprava za hrano in zdravila (Korean Food and Drug Administration – KFDA), dosežen znaten napredek.
The amendment introduced in 2003 brought some improvements to the screening of functional cosmetics, by accepting ‘in vivo’ test data, accepting efficacy data for the whole formula (instead of data for specific active ingredients), waiving certain products from efficacy screening and improving the ingredient specification.
Sprememba iz leta 2003 je prinesla nekaj izboljšav v zvezi s pregledom uporabnih kozmetičnih izdelkov, saj so bili z njo sprejeti podatki in vivo preskusov, podatki za celotne formule (namesto podatkov za specifične aktivne sestavine), opuščen pregled učinkovitosti za nekatere izdelke in izboljšan opis sestavin.
The amendment adopted in 2004 waived the requirement of stability data, further improved ingredient specification, and listed a number of active ingredients as exempted from efficacy screening.
S spremembo iz leta 2004 je bila odpravljena zahteva za podatke o stabilnosti, še dodatno izboljšan opis sestavin, in narejen seznam številnih aktivnih sestavin, izvzetih iz pregleda učinkovitosti.
However, some issues remained unresolved and the importers of EU cosmetics could still not benefit from most of the improvements brought by those amendments due to the strict interpretation and application of the Korean regulations by KFDA in practice.
Kljub temu pa so nekatera vprašanja ostala odprta, uvozniki v EU pa še zmeraj niso imeti koristi od večine izboljšav, ki so bile posledica navedenih sprememb, saj je KFDA rigorozno razlagala in izvajala korejske predpise.
After four years of continued discussions, the Korean authorities have finally agreed to remove the remaining obstacles on imports and sale of EU cosmetic products in Korea resulting from the implementation of the Korean regulations.
Po štirih letih neprekinjenih razprav so se korejski organi nazadnje strinjali z odpravo še zadnjih ovir za uvoz in prodajo kozmetičnih izdelkov EU v Koreji, ki so posledica izvajanja korejskih pravil.
Those commitments consist, more specifically in: (a) the determination on a case-by-case basis, subject to review, and taking into account the product as a whole, of whether the label of a cosmetic product leads the consumer to believe that it is a functional cosmetic product (therefore subject to efficacy screening); (b) the recognition of before-and-after comparison tests on finished products (as compared to earlier requirement of comparison tests using placebos); (c) less burdensome procedures for registration and in-market control of anti-wrinkle products; (d) the exemption from efficacy data of same-line products; (e) increased transparency on the approval of active ingredients of functional cosmetics; (f) in relation to customs clearance of imported cosmetic products, the elimination of the obligation to provide confidential data to the Korean industry association and the commitment to specific deadlines; (g) consultation with importers in relation to the preparation, adoption and application of legislation and administrative guidelines related to cosmetic products.
Zlasti so se zavezali k naslednjemu: (a) na podlagi proučitve vsakega primera posebej določiti - z možnostjo ponovnega pregleda in ob upoštevanju izdelka kot celote -, ali na podlagi oznake kozmetičnega izdelka potrošnik lahko sklepa, da gre za uporaben kozmetični izdelek (za katerega velja pregled učinkovitosti); (b) priznati primerjalne preskuse prej–potem na končnih izdelkih (v primerjavi s prej zahtevanimi primerjalnimi preskusi z uporabo placeba); (c) uporabljati manj zapletene postopke za registracijo in nadzor izdelkov proti gubam po sprostitvi v promet; (d) iz obveze zagotavljanja podatkov o učinkovitosti izvzeti izdelke iste linije; (e) povečati transparentnost pri odobritvi aktivnih sestavin uporabnih kozmetičnih izdelkov; (f) v zvezi s carinjenjem uvoženih kozmetičnih izdelkov odpraviti obveze za zagotovitev zaupnih podatkov korejskemu industrijskemu združenju in obveze glede posebnih rokov; (g) izvajati posvetovanje z uvozniki v zvezi s pripravo, sprejetjem in izvajanjem zakonodaje in upravnih smernic, povezanih s kozmetičnimi izdelki.
These commitments are considered by the complainant (COLIPA) as satisfactory.
Te obveze je pritožnik (COLIPA) štel za zadovoljive.
CONCLUSION AND RECOMMENDATIONS
SKLEPNA UGOTOVITEV IN PRIPOROČILA
In view of the above analysis, it is considered that the examination procedure has led to a satisfactory situation with regard to the obstacles that faced the trade as alleged in the complaint lodged by COLIPA.
Na podlagi zgornje analize se šteje, da je izid postopka preverjanja zadovoljiv v zvezi z ovirami za trgovino, o katerih je COLIPA vložil pritožbo.
The Advisory Committee has been consulted on the measures provided for in this Decision,
V zvezi z ukrepi iz te odločbe je bilo opravljeno posvetovanje s svetovalnim odborom –
The examination procedure concerning the measures imposed by the Republic of Korea affecting the import, distribution and advertising of cosmetics, perfume and toiletries products is hereby terminated.
Postopek preverjanja v zvezi z ukrepi, ki jih je uvedla Republika Koreja za uvoz, distribucijo in oglaševanje kozmetičnih izdelkov, dišav in izdelkov za osebno nego, se s tem zaključi.
Done at Brussels, 10 September 2008.
V Bruslju, 10. septembra 2008
OJ C 154, 19.5.1998, p. 12.
UL C 154, 19.5.1998, str. 12.
OJ L 4, 9.1.2001, p. 29.
UL L 4, 9.1.2001, str. 29.
concerning the non-inclusion of triflumizole in Annex I to Council Directive 91/414/EEC and the withdrawal of authorisations for plant protection products containing that substance
o nevključitvi triflumizola v Prilogo I k Direktivi Sveta 91/414/EGS in o preklicu registracij fitofarmacevtskih sredstev, ki vsebujejo navedeno snov
(notified under document number C(2008) 5075)
(notificirano pod dokumentarno številko C(2008) 5075)
That list includes triflumizole.
Navedeni seznam vključuje triflumizol.
For triflumizole the effects on human health and the environment have been assessed in accordance with the provisions laid down in Regulations (EC) No 451/2000 and (EC) No 1490/2002 for a range of uses proposed by the notifier.
Vplivi triflumizola na zdravje ljudi in okolje so bili ocenjeni v skladu z določbami uredb (ES) št. 451/2000 in (ES) št. 1490/2002 za vrste uporab, ki jih je predlagal prijavitelj.
For triflumizole the rapporteur Member State was the Netherlands and all relevant information was submitted on 4 January 2006.
Država članica poročevalka za triflumizol je bila Nizozemska, vse ustrezne informacije pa so bile predložene 4. januarja 2006.
The Commission examined triflumizole in accordance with Article 11a of Regulation (EC) No 1490/2002.
Komisija je preučila triflumizol v skladu s členom 11a Uredbe (ES) št. 1490/2002.
During the examination of this active substance by the Committee, taking into account comments from Member States, it was concluded that there are clear indications that it may be expected that it has harmful effects on human health and in particular the exposure of operator and worker is greater than 100 % of the AOEL.
Odbor je med preučevanjem te aktivne snovi ob upoštevanju pripomb držav članic ugotovil, da obstajajo jasni znaki, na podlagi katerih se lahko pričakuje, da ima aktivna snov škodljive učinke na zdravje ljudi ter da je zlasti izpostavljenost izvajalcev tretiranja in delavcev večja od 100 % AOEL.
The Commission invited the notifier to submit its comments on the results of the examination of triflumizole and on its intention or not to further support the substance.
Komisija je prijavitelja pozvala, naj predloži pripombe o rezultatih preučitve triflumizola in sporoči, ali bo še naprej vztrajal pri vključitvi navedene snovi na seznam.
However, despite the arguments put forwards by the notifier, the concerns identified could not be eliminated, and assessments made on the basis of the information submitted have not demonstrated that it may be expected that, under the proposed conditions of use, plant protection products containing triflumizole satisfy in general the requirements laid down in Article 5(1)(a) and (b) of Directive 91/414/EEC.
Toda kljub argumentom, ki jih je prijavitelj predložil, se navedenih pomislekov ni dalo odpraviti, po ocenah na podlagi predloženih informacij pa ne kaže pričakovati, da bi lahko fitofarmacevtska sredstva, ki vsebujejo triflumizol, pod predvidenimi pogoji uporabe na splošno izpolnjevala zahteve iz člena 5(1)(a) in (b) Direktive 91/414/EGS.
Triflumizole should therefore not be included in Annex I to Directive 91/414/EEC.
Triflumizol se zato ne sme vključiti v Prilogo I k Direktivi 91/414/EGS.
Measures should be taken to ensure that authorisations granted for plant protection products containing triflumizole are withdrawn within a fixed period of time and are not renewed and that no new authorisations for such products are granted.
Sprejeti je treba ukrepe za zagotovitev, da se registracije fitofarmacevtskih sredstev, ki vsebujejo triflumizol, prekličejo v predpisanem roku in se ne podaljšajo ali izdajo nove registracije takih sredstev.
Any period of grace granted by a Member State for the disposal, storage, placing on the market and use of existing stocks of plant protection products containing triflumizole should be limited to 12 months in order to allow existing stocks to be used in one further growing season, which ensures that plant protection products containing triflumizole remain available for 18 months from the adoption of this Decision.
Če države članice odobrijo podaljšanje roka za odstranjevanje, skladiščenje, dajanje v promet in uporabo obstoječih zalog fitofarmacevtskih sredstev, ki vsebujejo triflumizol, ga je treba omejiti na obdobje 12 mesecev, da se omogoči uporaba obstoječih zalog v naslednji rastni sezoni, s čimer se zagotovi, da fitofarmacevtska sredstva, ki vsebujejo triflumizol, ostanejo na razpolago 18 mesecev po sprejetju te odločbe.
This Decision does not prejudice the submission of an application for triflumizole in accordance with Article 6(2) of Directive 91/414/EEC and Commission Regulation (EC) No 33/2008 of 17 January 2008 laying down detailed rules for the application of Council Directive 91/414/EEC as regards a regular and an accelerated procedure for the assessment of active substances which were part of the programme of work referred to in Article 8(2) of that Directive but have not been included into its Annex I [4], in view of a possible inclusion in its Annex I.
Ta odločba ne vpliva na predložitev zahtevka za triflumizol v skladu s členom 6(2) Direktive 91/414/EGS in Uredbo Komisije (ES) št. 33/2008 z dne 17. januarja 2008 o podrobnih pravilih za izvajanje Direktive Sveta 91/414/EGS glede rednega in pospešenega postopka za oceno aktivnih snovi, ki so bile del delovnega programa iz člena 8(2) navedene direktive, vendar niso bile vključene v Prilogo I [4], zaradi morebitne vključitve v Prilogo I k navedeni direktivi.
Triflumizole shall not be included as an active substance in Annex I to Directive 91/414/EEC.
Triflumizol se ne vključi kot aktivna snov v Prilogo I k Direktivi 91/414/EGS.
authorisations for plant protection products containing triflumizole are withdrawn by 18 March 2009;
se registracije fitofarmacevtskih sredstev, ki vsebujejo triflumizol, prekličejo do 18. marca 2009;
no authorisations for plant protection products containing triflumizole are granted or renewed from the date of publication of this Decision.
se od datuma objave te odločbe nobene registracije fitofarmacevtskih sredstev, ki vsebujejo triflumizol, ne odobrijo ali podaljšajo.
amending Decision 2003/77/EC laying down multiannual financial guidelines for managing the assets of the ECSC in liquidation and, on completion of the liquidation, the Assets of the Research Fund for Coal and Steel
o spremembi Odločbe 2003/77/ES o določitvi večletnih finančnih smernic za upravljanje sredstev ESPJ v likvidaciji in po končani likvidaciji za upravljanje sredstev Raziskovalnega sklada za premog in jeklo
Having regard to the Protocol annexed to the Treaty establishing the European Community on the financial consequences of the expiry of the ECSC Treaty and on the Research Fund for Coal and Steel,
ob upoštevanju Protokola o finančnih posledicah izteka Pogodbe o ESPJ in o Raziskovalnem skladu za premog in jeklo, ki je priložen Pogodbi o ustanovitvi Evropske skupnosti,
Having regard to Council Decision 2003/76/EC of 1 February 2003 establishing the measures necessary for the implementation of the Protocol, annexed to the Treaty establishing the European Community, on the financial consequences of the expiry of the ECSC Treaty and on the Research Fund for Coal and Steel [1], and in particular Article 2(2) thereof,
ob upoštevanju Odločbe Sveta 2003/76/ES z dne 1. februarja 2003 o določitvi ukrepov za izvajanje Protokola o finančnih posledicah izteka Pogodbe o ESPJ in o Raziskovalnem skladu za premog in jeklo, ki je priložen k Pogodbi o ustanovitvi Evropske skupnosti [1], ter zlasti člena 2(2) Odločbe,
For the purposes of the Protocol annexed to the Treaty establishing the European Community on the financial consequences of the expiry of the ECSC Treaty and on the Research Fund for Coal and Steel, the Commission manages the assets of the ECSC in liquidation and, on completion of the liquidation, the Assets of the Research Fund for Coal and Steel.
Za namene Protokola o finančnih posledicah izteka Pogodbe o ESPJ in o Raziskovalnem skladu za premog in jeklo, ki je priložen Pogodbi o ustanovitvi Evropske skupnosti, Komisija upravlja sredstva ESPJ v likvidaciji in po končani likvidaciji sredstva Raziskovalnega sklada za premog in jeklo.
In accordance with Article 2 of Decision 2003/77/EC [3], the Commission has reassessed the operation and effectiveness of the financial guidelines.
V skladu s členom 2 Odločbe 2003/77/ES [3] je Komisija ponovno ocenila delovanje in učinkovitost finančnih smernic.